We are live on ! Find out more
LABD icon

Direxion Daily S&P Biotech Bear 3X ETF
LABD

14 hedge funds and large institutions have $7.33M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

645% more call options, than puts

Call options by funds: $5.74M | Put options by funds: $771K

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

85% more capital invested

Capital invested by funds: $3.98M → $7.33M (+$3.36M)

56% more funds holding

Funds holding: 9 → 14 (+5)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0% more ownership

Funds ownership: 0% → 0.01% (+0%)

Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
2
Closed
1
Calls
$5.74M
Puts
$771K
Net Calls
+$4.97M
Net Calls Change
+$1.15M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.35M
2
VKH
Virtu KCG Holdings
New York
+$923K
3
TRCT
Tower Research Capital (TRC)
New York
+$885K
4
HF
HRT Financial
New York
+$346K
5
CT
CMT Trading
Illinois
+$269K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$923K
2
Citadel Advisors
Citadel Advisors
Florida
-$356K
3
Simplex Trading
Simplex Trading
Illinois
-$154K
4
Creative Planning
Creative Planning
Kansas
-$16K
5
TCM
Tradewinds Capital Management
Washington
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1.32M +$1.35M +35 New
VKH
2
Virtu KCG Holdings
New York
$1.29M +$923K +24 +240%
VF
3
Virtu Financial
New York
$1.22M -$923K -24 -43%
TRCT
4
Tower Research Capital (TRC)
New York
$1.1M +$885K +23 +383%
Jane Street
5
Jane Street
New York
$977K +$269K +7 +37%
HF
6
HRT Financial
New York
$340K +$346K +9 New
CT
7
CMT Trading
Illinois
$256K +$269K +7 New
TSS
8
Two Sigma Securities
New York
$242K +$231K +6 New
Simplex Trading
9
Simplex Trading
Illinois
$225K -$154K -4 -40%
FTUS
10
Flow Traders U.S.
New York
$154K +$154K +4 New
CG
11
Cutler Group
California
$62K – – –
USGIU
12
U.S. Global Investors (USGI)
Texas
$57K +$76.9K +2 New
UBS Group
13
UBS Group
Switzerland
$56K – – –
Morgan Stanley
14
Morgan Stanley
New York
$40K – – –
Citadel Advisors
15
Citadel Advisors
Florida
– -$356K -10 Closed
Creative Planning
16
Creative Planning
Kansas
– -$16K – –
TCM
17
Tradewinds Capital Management
Washington
– -$13K – –

LABD Hedge Fund Activity: Q4 2016 in Review

14 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q4 2016, worth a combined $7.33M — up 85% from $3.98M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new LABD positions and 1 closed out — a net gain of 5 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.35M. The largest seller was Virtu Financial, cutting an estimated $923K.

  • 14 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q4 2016, up from 9 in Q3 2016.
  • Funds reported $7.33M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q4 2016, up 85% quarter-over-quarter.
  • 6 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q4 2016 and 1 closed out, a net change of +5 holders.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q4 2016 was Susquehanna International Group, an estimated $1.35M added.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q4 2016 was Virtu Financial, an estimated $923K sold.

Based on aggregated 13F filings for Q4 2016.